-
| Sector | Healthcare |
|---|---|
| Industry | Diagnostics & Research |
| ISIN | KYG5262E1044 |
| Exchange | HK |
| CurrencyCode | HKD |
| PE Ratio | None |
|---|---|
| Beta | 0.61 |
| Market Cap | 1B |
| Target Price | 3.22 |
| Dividend Yield | 8.5% |
Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People's Republic of China and Mainland China. It operates through nine segments: Hematology Testing. Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, Routine Testing, CROs and R&D Project, and Others. The company offers esoteric testing services for hematology, oncology, neuroscience and infectious diseases. It also engages in product development and technical services; reagent development and sales; car-t treatment; and E-commerce services. The company's research and development projects, including molecular biology detection, flow cytometry detection, cytogenetic detection, and pathological detection technologies. Kindstar Globalgene Technology, Inc. was founded in 2003 and is headquartered in Wuhan, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 9960.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026